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Abstract The Epstein-Barr virus nuclear antigen 2 (EBNA2) 
gene is thought to be important for transformation by Epstein-
Barr virus (EBV), but the mechanism of this transformation is 
little understood. Here, to examine the transforming ability of 
EBNA2, we transfected a rat fibroblast cell line F2408 with a 
recombinant EBNA2 expression plasmid and examined cell mor-
phology, colony formation in soft agar, and tumorigenicity in 
nude mice. The morphology of transfected clones was similar to 
those of untransfected cells, but two of seven clones grew in soft 
agar, and four clones of seven clones reproducibly formed tumors 
in nude mice. These four clones showed EBNA2 expression, but 
non-tumorigenic clones did not. These results indicate that the 
expression of EBNA2 is correlated with tumorigenicity. 
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1. Introduction 
Epstein-Barr virus (EBY) is well known to be an etiological 
agent m endemic Burkitt lymphoma, nasopharyngeal carci-
noma (NPC) and lymphomas in immunodeficiency [I]. Re-
cently, Hodgkin's disease [2], Ki-I-positive anaplastic large cell 
lymphoma [3,4] and a part of gastric carcinoma [5] have also 
been reported to be closely related to EBY. However, the mech-
anism of tumorigenesis by EBY is not well understood. The 
transforming genes of EBY are suspected to be in the region 
of EBY associated nuclear antigens (EBNAs) and latent mem-
brane protein (LMP)I [6]. LMPI can transform established 
rodent cells. Expression of LMPl resulted in altered cell mor-
phology and growth in low serum and in soft agar. Further. 
Rat-l cells expressing LMPI were tumorigenic in nude mice [7]. 
LMPI \\ as also expressed in 40% of nasopharyngeal carCi-
noma [8], 
EBNA2, encoded by the IRI and the U2 regions of EBY 
genome, seems to be important for B cell immortalization, 
because P3HR-I virus, the genome of which lacks the EBNA2 
coding region cannot immortalize lymphocytes [9]. There are 
also reports that EBNA2 is essential for B-Iymphocyte growth 
transformation [10,11]. These findings suggest the important 
role of EBNA2 in transformation. Transactivation of CD21 
[12], CD23 [13], c-fgr [14] and LMPI [15.16] has been demon-
strated and thought to be a mechanism of lymphocyte Immor-
tahzation by EBNA2. But the process and mechanism oftumo-
rigenesis by EBNA2 is now unclear. 
Here. we examined the transformmg phenotype of EBNA2 
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transfected rat fibroblast cell line F2408 and found a correla-
tion between the tumorigenicity and the expression of EBNA2. 
2. Materials and methods 
2.1 Transfeetion 
Recombinant pZ-E2 (pZlp NEO SV(X)I/EBNA2 DNA) [17], ob-
tained from E. Kleff (Harvard University). contams the EBNA2 open 
reading frame driven by the murine leukemia virus long terminal repeat. 
Fi~her rat F240S fibroblasts were transfected with recombinant pZ-E2 
plasmid by the calcium phosphate transfection method After selection 
in medium supplemented with the neomycin analog G4IS, we obtained 
seven G4lS-reslstant F240S clones (F240S-E2). 
::.2. Southern blot analYSIS 
DNAs were extracted by proteinase K, phenol/chloroform method. 
from cultured cells. Ten micrograms of DNA from each speCimen were 
digested with the restriction enzymes HzndIII and BamHI. subjected to 
electrophoresis on a O.S% agarose gel. transferred to a nylon membrane 
(Biodyne. Pall) by blottmg and hybridized with labeled E2 DNA. 
2.3. Northern hlot analYSIS 
RNAs were purified from cultured cells with guamdium thiocyanate 
followed by centrifugation in cecium chloride solution [1S]. Poly (A+) 
RNAs were selected with oligo-dT latex (Ohgotex. Roche), electro-
phoresed through 1.4% agarose gels containmg formaldehyde. trans-
ferred to nylon membranes (BlOdyne. Pall), and hybridized with the 
labeled E2 DNA as a probe. 
:: 4 Indirect Immunofluorescence stailllng 
Specimens offrozen tissue or cultured cells on chamber slides (Nunc) 
were fixed with equal quantities of acetone and methanol for 5 min at 
4°C. Monoclonal anti-EBNA2 antibody PE2 (Dako) were diluted 20 
times With PBS and reacted for 90 min at 37°C. After washmg twice 
with PBS. biotinylated goat anti-human IgG or anti-mouse IgG (BRL) 
was diluted 50 times With PBS and reacted for 60 min at 37°C After 
washmg tWice with PBS. 200 times-diluted streptavidin-ftuorescem iso-
thiocyanate conJugate (BRL) ""as reacted for 45 mm at room tempera-
ture. After washmg three times with PBS. the slides were sealed with 
glycenn contaming 0 22 M l.-l-dlazohlcyclo-octane (DABCO) (Wako. 
Osaka). 
3. Results 
3.1. Tramjormed phenotJpes of EBN A2-tramjected cells 
We transfected pZ-E2 into rat fibroblast F2408. selected 
seven clones and examined various transformed phenotypes of 
these clones, These clones contained the EBNA2 gene detected 
by Soutern blotting analysis (data not shown). The morphology 
and the saturation densities of seven clones were similar to 
those of untransfected cells or cells transfected with the plasmid 
without E2. Two of these clones grew in 0.33% soft agar 
(Table I). 
Subcutaneous inoculation of E2 transfected clones at 2 x 10" 
cells per mouse into nude mice induced tumors in four of the 
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Fig. I. Histological appearance of a tumor induced in a nude mouse 
6 weeks after injectIOn of 2 x 106 F2408-E2 cells. H-E staining. x 400. 
seven clones after 2-3 weeks, whereas cells transfected with 
vector plasmid without E2 did not induce tumors (Table I). 
These tumors were undifferentiated sarcomas with many mi-
totic cells (Fig. I) and few collagen fibers stained with the 
Azan-Mallory staining. Southern blot analysis of these tumor 
tissue showed retention of E2 DNA (Fig. 2). 
These results indicated that EBNA2 conferred tumorigen-
icity and anchorage independency on the established cell line. 
Table I 
Transforming actiVIty of EBNA-2 
Clones Saturation Colony Growth in Tumorigeni-
densIty' formation low serum" city 
(X 10" in soft agar+ (X 105 in nude 
cells/lO cm cells/plate) mice ++ 
plate) 
EBNA2 
CI.I4 0.99 0 0.50 0/3 
CL23 0.83 0 0.87 0/3 
CL28 ND' 0 0.65 0/3 
CL9 1.10 0 3.0 6/6 
CI16 0.98 0 4.0 6/6 
CI.I8 ND 123.5 3.5 3/3 
CL24 ND 27.0 3.5 3/3 
pZlpNeo 
CI2 0.76 0 0.56 0/3 
CI.4 ND ND 0.25 0/3 
CL6 1.06 0 0.88 0/3 
F2408 0.89 0 0.75 0/3 
'F2408 cells contaming the indicated clones were plated onto 10 cm 
plates. The number of cells in two plates was counted dally. and the 
maxImum cell number (average for two plates) is shown as the satura-
tion denSIty. 
+2 x 104 cells were seeded into 6 cm plastic plate with 0.33% noble agar 
in DMEM supplemented with 5% FCS on top of 0 5% base agar. The 
number of colonies larger than 0.125 mm was counted after culture for 
3 weeks. Average for two experiments IS shown. 
"2 x 105 cells were seeded in 10 cm plastic plate with 10 ml medium 
con taming 0.1 % FCS. Medium was changed each 3 or 4 days. The 
number of cells were counted after 10 days. Average for three experi-
ments is shown. 
++2 x 106 G418-resistant cells were mjected into nude mIce. (The num-
ber of mice with tumour)l(the number of mice moculated) is shown. 
'ND. not done. 
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FIg. 2. Southern blot analysis of tumors induced by F2408-E2 CL9. 
Lane I. F2408-pZip; lane 2, F2408-E2 CL9; lane 3 through 6, tumors 
I, 2, 3, 4 mduced by F2408-E2 CL9. respectIvely. Each lane con tamed 
30 flg of DNA treated with 150 units of the restrictIOn enzyme HmdIII. 
Next we examined cell growth of these clones in media with 
low serum. Tumorigenic clones grew slightly in low serum, but 
the non-tumorigenic or control clones did not grow under these 
conditions (Table I). Therefore, EBNA2 provided the cells with 
a growth capacity on low serum conditions as well as tumo-
rigenicity. 
3.2. Expression of EBNA2 
To explain the difference between tumorigenic and non-tu-
morigenic clones, we studied the expression of ENBA2 on these 
clones. Poly(A +) RNAs selected from total RNAs of F2408-E2 
clones and control clones were analysed by Northern blot 
hydbridization. We detected a distinct hybridization band in 
2 3 4 5 6 7 8 9 10 
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FIg. 3. EBNA2 RNA expression m transfected F2408-E2. Northern 
blot was prepared by electrophoresis of polyadenylated RNA from 
200 flg each total RNA m I 4% agarose-2.2 M formaldehyde gel. fol-
lowed by transfer to a nylon membrane filter. The blot was hybrIdized 
succeSSIvely WIth 3 x 106 cmp/mllabelled E2 DNA or actin sequence. 
Lane I. pZip-transfected F2408 Cl.2; lane 2, F2408-E2 C1.I4; lane 3, 
F2408- E2 Cl.23, lane 4. F2408-E2 CL28; lane 5, F2408-E2 Cl.9; lane 
6, F2408-E2 Cl.16; lane 7. F2408-E2 CLI8; lane 8, F2408-E2 Cl.24; lane 
9, P3HRI cells which delete EBNA2 gene; lane 10, Raji cells as positive 
control for EBNA2. 
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Fig. 4. Immunofluorescence of E2-expressing cells. Cells were stained with monoclonal antibody PE2. The nuclei of the cells were stained. A. F2408-E2 
Cl.24 cells. x 100. B, F2408-E2 Cl.9 cells. x 100: C, F2408- E2 Cl.23 cells (left). F2408-E2 C1.28 cells (middle). and F2408-pZip CI.4 cells (right), x 50: 
D. recultured cells of F2408-E2 Cl.9. x 100. Control stainmgs with PBS were shown m parentheses. x 50. 
one clone 24. but not in other clones (Fig. 3). Because the 
expression of EBNA2 may be too low to be detected by North-
ern blotting. we tried another method. Immunofluorescence 
staining using monoclonal EBNA2 antibody showed distinct 
fluorescence in clone 24 and weak fluorescence in other tumo-
rigenic clones. whereas no fluorescence was detected in non-
tumorigenic clones and clones transfected with the vector only 
(Fig. 4A, B. C). Nuclei of recultured cells from induced tumor 
also showed fluorescence when stained with this antibody (Fig. 
4D). 
All these results suggest that the EBNA2 gene of EBV causes 
tumorigenicity. 
4. Discussion 
We showed tumorigenicity in nude mice and growth ability 
in low serum of EBNA2-expressing cells. 
Although we detected EBNA2 expression in only one clone 
by Northern blotting, we could show all the tumorigenic clones 
to express EBNA2 by immunofluorescence staining. This fact 
suggests that weak EBNA2 expression may be sufficient to 
induce tumors and that this may be related to unsuccessful 
detection of EBNA2 expression in various human tumors. 
We also showed that some EBNA2-transfected clones were 
anchorage-independent, and tumorigenicity and decreased 
serum requirement did not correlate with anchorage indepen-
dency. Higher expression of EBNA2 may be necessary to in-
duce anchorage independency than to induce tumorigenicity. 
Alternatively, dissociation of tumorigenicity and decreased 
serum requirement from anchorage independency has been re-
ported in cells transfected with the E6 gene of human papillo-
mavirus type 16 [19]. 
Dambaugh et al. reported that Rat-I cells expressing EBNA2 
grew in medium with 0.5% fetal calf serum but remained con-
tact inhibited, anchorage-dependent and non-tumorigenic in 
mice [17). ThiS report differs from our data on many points but 
the efficiency of tumorigenicity or anchorage independency 
may be dependent on the type of cells transfected. 
We examined the state of c-myc in tumorigenic and non-
tumorigenic clones, because rearrangement and overexpression 
of the C-IIl)'C gene has been reported with EBV-induced Burkitt 
lymphoma [20,21). But we found no difference in the restriction 
enzyme digestion pattern of the c-myc gene between tumo-
rigemc and non-tumorigenic clones by Southern blot analyses 
(data not shown). This experiment showed that the difference 
between tumorigenic and non-tumorigenic clones was not due 
to activation of the c-myc gene. 
These results indicate that the EBNA2 gene possesses trans-
forming activity. 
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